FDA Inspection 1303060 — LifeLink of Puerto Rico
The FDA completed an inspection of LifeLink of Puerto Rico on January 23, 2026 in Guaynabo, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 23, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Guaynabo, PR (United States)